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INVITED COMMENTARYResponse to commentary on ‘Angiosarcoma as a Potential
Consequence of Autologous Lymph Node Transplantation
for Lymphoedema’
Authors reported the occurrence of angiosarcoma in
a patient with lower limb primary lymphoedema. Two ALNT
were practiced 7 and 14 years before angiosarcoma onset.
Angiosarcoma may occur in patient with primary lymphoe-
dema.1e3 It is possible that angiosarcoma is fortuitous and
not related to previous ALNT.
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Although popliteal artery aneurysms (PAA) are the most
common peripheral arterial aneurysms, their incidence is
low, making meaningful observations from single center
series almost impossible due to variations in presentation
and anatomic features. Therefore, retrospective multicenter
registry studies combining the experiences of several
centers, as was performed by Pulli et al.1 have been con-
ducted in an attempt to identify the optimal treatment
options, especially after the adoption of endovascular
popliteal artery aneurysm repairs (EVPAR). The disadvan-
tage of such studies includes the lack of a standardised
protocol for data collection.
Despite the relatively low frequency of PAA, the optimal
treatment requires highly individualized treatment plan-
ning, and is determined by the mode of presentation (acute
vs. nonacute, severity of ischemia, symptomatic vs.
asymptomatic), medical condition, functional capacity andactivity level of the patient, as well as anatomic charac-
teristics (condition of the runoff vessels in the acute and
chronic setting, proximal and distal extent of the aneu-
rysm). Pulli et al. did not make any direct comparisons
between endovascular or open treated patients as they
were signiﬁcantly different from clinical and anatomic
aspects, and their overall outcomes were excellent. The
patients treated with open repair in this series were more
likely to present with acute limb ischemia (ALI), including
patients with the most severe (Rutherford grade 2b)
ischemia, or other chronic symptoms. Unfortunately, they
did not present their patency data separately in patients
who presented acutely from those who were treated
electively, making it harder to evaluate the outcomes
following open repair and EVPAR.
Patients with PAA with ALI are particularly challenging. In
a systematic review of the literature between 1990 and
2008 (895 patients with ALI, Kropman et al.2) there was
a 14.1% amputation rate and no signiﬁcant difference in
amputation rates with or without thrombolysis before
surgery. The authors of the current study have previously
reported better outcomes following successful thrombol-
ysis,3 but patients with more severe ischemia are typically
subjected to open repair. Thrombolysis was used only in
patients who presented with grade I or IIa ischemia in the
current study, which is generally the recommended
approach. However, with the increased availability of hybrid
rooms, and familiarity of surgeons with new thrombectomy
devices (e.g. rheolytic thrombectomy), accelerated throm-
bolysis (e.g. power pulse thrombolysis, US-assisted throm-
bolysis), endovascular recanalization using a combination of
these techniques with early exclusion of the thrombosis
with covered stents followed by “toilet” thrombolysis is
increasingly used, even in patients with advanced ischemia.
This approach can reinstitute blood ﬂow to the extremity
faster than a surgical approach, especially in those with no
target vessels on the initial angiogram.
Due to the risk of secondary embolism being catastrophic
in patients with thrombolysis, primary bypass is preferred
as the initial treatment in patients with a patent artery to
the foot, especially in patients with good autologous vein.
Aulivola et al.4 reported comparable outcomes in patients
with emergent and nonemergent presentations, using
aggressive surgical bypass in patients with distal target
vessels, and utilizing thrombolysis only in those without any
identiﬁable target vessels. Thrombolysis is still used by
many due to reports suggesting that it improves runoff
vessels, while others suggest that it should be reserved for
patients whose clot extends to the trifurcation vessels, with
primary bypass for those with clot that is conﬁned to the
popliteal artery, as one has nothing to gain, but potentially
much to lose if embolization occurs.5
The current report is no exception in reporting the best
outcomes following surgical repair using autologous grafts,
(mainly GSV), with a 48 month primary patency (PP) rate of
